Related references
Note: Only part of the references are listed.HIV Infection Deregulates Tim-3 Expression on Innate Cells: Combination Antiretroviral Therapy Results in Partial Restoration
Constance A. M. Finney et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Galectin-9 Functionally Impairs Natural Killer Cells in Humans and Mice
Lucy Golden-Mason et al.
JOURNAL OF VIROLOGY (2013)
TIM-3 Does Not Act as a Receptor for Galectin-9
Judith Leitner et al.
PLOS PATHOGENS (2013)
Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
Lishomwa C. Ndhlovu et al.
BLOOD (2012)
Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9
Michelle K. Gleason et al.
BLOOD (2012)
Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection
Shokrollah Elahi et al.
BLOOD (2012)
Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
Hang Li et al.
HEPATOLOGY (2012)
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
Shigeki Chiba et al.
NATURE IMMUNOLOGY (2012)
Tim-3 Negatively Regulates Cytotoxicity in Exhausted CD8+ T Cells in HIV Infection
Ali Sakhdari et al.
PLOS ONE (2012)
HIV-1 adaptation to NK-cell-mediated immune pressure
Galit Alter et al.
NATURE (2011)
Cross-Sectional Detection of Acute HIV Infection: Timing of Transmission, Inflammation and Antiretroviral Therapy
Cynthia Gay et al.
PLOS ONE (2011)
Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry
Shuguang Bi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression
Bahareh Vali et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Innate immunity defines the capacity of antiviral T cells to limit persistent infection
Daniel M. Andrews et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B
Ying Ju et al.
JOURNAL OF HEPATOLOGY (2010)
HIV Protective KIR3DL1 and HLA-B Genotypes Influence NK Cell Function Following Stimulation with HLA-Devoid Cells
Salix Boulet et al.
JOURNAL OF IMMUNOLOGY (2010)
T Cell/Transmembrane, Ig, and Mucin-3 Allelic Variants Differentially Recognize Phosphatidylserine and Mediate Phagocytosis of Apoptotic Cells
Rosemarie H. DeKruyff et al.
JOURNAL OF IMMUNOLOGY (2010)
Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation
Masafumi Nakayama et al.
BLOOD (2009)
HLA Class I Subtype-Dependent Expansion of KIR3DS1+ and KIR3DL1+ NK Cells during Acute Human Immunodeficiency Virus Type 1 Infection
Galit Alter et al.
JOURNAL OF VIROLOGY (2009)
Role of Natural Killer Cells in a Cohort of Elite Suppressors: Low Frequency of the Protective KIR3DS1 Allele and Limited Inhibition of Human Immunodeficiency Virus Type 1 Replication In Vitro
Karen A. O'Connell et al.
JOURNAL OF VIROLOGY (2009)
Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections
Andrea R. Stacey et al.
JOURNAL OF VIROLOGY (2009)
Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells
Lucy Golden-Mason et al.
JOURNAL OF VIROLOGY (2009)
A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection
Salix Boulet et al.
AIDS (2008)
Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals
Salix Boulet et al.
AIDS (2008)
IL-21 augments natural killer effector functions in chronically HIV-infected individuals
Natasa Strbo et al.
AIDS (2008)
Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways
Shuguang Bi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
R. Brad Jones et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes
Galit Alter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells
Ana C. Anderson et al.
SCIENCE (2007)
Natural killer cells promote early CD8 T cell responses against cytomegalovirus
Scott H. Robbins et al.
PLOS PATHOGENS (2007)
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1
Maureen P. Martin et al.
NATURE GENETICS (2007)
T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface
Erhu Cao et al.
IMMUNITY (2007)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection
G Alter et al.
BLOOD (2005)
Characterization of CD56-/CD16+ natural killer (NK) cells:: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals
D Mavilio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
CD107a as a functional marker for the identification of natural killer cell activity
G Alter et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance
CA Sabatos et al.
NATURE IMMUNOLOGY (2003)
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
L Monney et al.
NATURE (2002)
Share Paper
